Insulin-like growth factor 2 in development and disease: A mini-review

Gerontology

Volumn 59, Issue 3, 2013, Pages 240-249

  Bergman, Daniel ^a   Halje, Matilda ^a   Nordin, Matilda ^a   Engström, Wilhelm ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Cancer; Cardiovascular disease; Gene expression; Growth factors

Indexed keywords

INSULIN RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; BINDING PROTEIN;

BECKWITH WIEDEMANN SYNDROME; CARDIOVASCULAR DISEASE; FETUS GROWTH; GENE STRUCTURE; GENOME IMPRINTING; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; ALPHA HELIX; APOPTOSIS; DISEASE COURSE; DISEASES; DISULFIDE BOND; GROWTH DISORDER; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TUMOR GROWTH;

ANIMALS; CARDIOVASCULAR DISEASES; DISEASE; FEMALE; GENOMIC IMPRINTING; GROWTH AND DEVELOPMENT; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR II; MALE; MICE; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 84877874915     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000343995     Document Type: Review

References (35)

1. Salmon WDJ, Daughaday WH: A hormon-ally controlled serum factor which stimulates sulphate incorporation by cartilage in vitro. J Lab Clin Med 1957; 49:825-836.
2. Rinderknecht E, Humbel RE: The amino acid sequence of human insulin like growth factor I and its structural homology with pro-insulin. J Biol Chem 1978; 253: 2769-2776.
3. Rinderknecht E, Humbel RE: Primary structure of insulin like growth factor II. FEBS Lett 1978; 89: 283-286.
4. Engström W, Shokrai A, Otte K, Granérus M, Gessbo A, Bierke P, Madej A, Sjölund M, Ward A: Transcriptional regulation and biological significance of the insulin like growth factor II gene. Cell Prolif 1998; 31: 173-189.
5. Sara VR, Hall K, Misaki M, Fryklund L, Christensen N, Wetterberg L: Ontogenesis of somatomedins and insulin receptors in the human fetus. J Clin Invest 1983; 71: 1084-1094.
6. Clemmons DR: Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 1997; 8:45-62.
7. de Chiara T, Robertson E, Efstradiatis A: Parental imprinting of the mouse insulin like growth factor II gene. Cell 1992; 64:849-859.
8. Qiu Q, Jiang JY, Bell M, Tsang, BK, Gruslin A: Activation of endoproteolytic processing of insulin-like growth factor-II in fetal, early postnatal, and pregnant rats and persistence of circulating levels in postnatal life. Endocrinology 2007; 148:4803-4811.
9. EntrezGene. NCBI database. ID 3481.
10. Alvino CL, Ong SC, McNeil KA, Delaine C, Booker GW, Wallace JC, Forbes BE: Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF II. PLoS One 2011; 6:e27488.
11. Hassan AB: Keys to the hidden treasures of the mannose 6-phosphate/insulin-like growth factor 2 receptor. Am J Pathol 2003; 162: 3-6.
12. Brown J, Esnouf RM, Jones MA, Linnell J, Harlos K, Hassan AB, Jones EY: Structure of a functional IGF-2R fragment determined from the anomalous scattering of sulfur. EMBO J 2002; 21:1054-1062.
13. Brown J, Jones E, Forbes BE: Interactions of IGF II with the IGF-2R/cation independent mannose-6-phosphate receptor mechanism and biological outcomes. Vitam Horm 2009; 80:699-719.
14. Ward A: Beckwith-Wiedemann syndrome and Wilms' tumour. Mol Hum Reprod 1997; 3:157-168.
15. Cheng I, Stram D, Burtt NP, Gianniny L, Garcia RR, Pooler L, Henderson BE, Le Marchand L, Haiman CA: IGF2R missense single-nucleotide polymorphisms and breast cancer risk. The multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2009; 18: 1922-1924.
16. Lönn S, Rothman N, Shapiro WR, Fine HA, Selker RG, Black PM, Loeffler JS, Hutchison AA, Inskip PD: Genetic variation in insulin like growth factors and brain tumor risk. Neuro Oncol 2008; 10: 553-559.
17. Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ: Analysis of genes critical for growth regulation identifies insulin like growth factor receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 1667-1674.
18. Favelyukis S, Till JH, Hubbard SR, Miller WT: Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat Struct Mol Biol 2001; 8:1058-1063.
19. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri L: Insulin receptor isoforms and insulin receptor/insulin like growth factor receptor hybrids in physiology and disease. Endocr Rev 2009; 30: 586-623.
20. Chao W, D'Amore PA: IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 2008; 19:111-120.
21. Pollak MN: Insulin-like growth factors and neoplasia. Novartis Found Symp 2004; 262: 84-98, discussion 98-107, 265-268.
22. Senthil D, Choudhury GG, Abboud HE, Sonenberg N, Kasinath BS: Regulation of protein synthesis by IGF-I in proximal tubular epithelial cells. Am J Physiol Renal Physi-ol 2002; 283:F1226-F1236.
23. Zheng H, Worral C, Stern H, Issad T, Sere-gard S, Girnita A, Girnita L: Selective recruitment of G-protein coupled receptor ki-nases controls signalling of the insulin like growth factor 1 receptor. Proc Natl Acad Sci USA 2012; 109:7055-7060.
24. López-Bermejo A, Buckway CK, Devi, GR, Hwa V, Plymate SR, Oh Y, Rosenfeld RG: Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium. Endocrinology 2000; 141:4072-4080.
25. Granérus M, Johannisson A, Ekblom P, Engström W: Insulin-like growth factors I and II induce cell death in Wilms's tumour cells. Mol Pat hol 2001; 54: 30-35.
26. Choufani S, Shuman C, Weksberg R: Beck-with-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2010; 154C:343-354.
27. Cerrato F, Sparago A, Verde G, De Crescenzo A, Citro V, Cubellis MV, Rinaldi MM, Boccuto L, Neri G, Magnani C, D'Angelo P, Collini P, Perotti, D, Sebastio G, Maher E, Riccio A: Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour. Hum Mol Genet 2008; 17:1427-1435.
28. Samani AA, Yakar S, LeRoith D, Brodt A: The role of the IGF system in cancer growth and metastasis. Overview and recent insights. Endocr Rev 2007; 28: 20-44.
29. Lahm H, Amstad P, Wyniger J, Yilmaz A, Fischer JR, Schreyer M, Givel JC: Blockade of the insulin like growth factor I receptor inhibits growth of human colorectal cancer cells. Evidence of a functional IGF II mediated autocrine loop. Int J Cancer 1994; 58: 452-459.
30. Cheng Y, Idrees K, Shattock R, Khan S, Zeng Z, Brennan C, Paty P, Barany F: Loss of imprinting and marked gene elevation are two forms of aberrant IGF2 expression in colorectal cancer. Int J Cancer 2010; 127:568-577.
31. Gao Y, Katki H, Graubard B, Pollack M, Martin M, Tao Y, Schoen RE, Church T, Hayes RB, Greene MH, Berndt SI: Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal carcinoma. Int J Cancer 2011; 131:E105-E113.
32. Colao A: The GH-IGF-1 axis and the cardiovascular system: clinical implications. Clin Endocrinol (Oxf) 2008; 69: 347-358.
33. Rodriguez S, Gaunt TR, ÓDell SD, Chen XH, Gu D, Hawe E, Miller GJ, Humphries SE, Day IN: Haplotypic analysis of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits. Hum Mol Genet 2004; 13: 715-725.
34. Zaina S, Pettersson L, Thomsen AB, Chai CM, Qi Z, Thyberg J, Nilsson J: Shortened life span, bradycardia and hypotension in mice with targeted expression of an IGF2 transgene in smooth muscle cells. Endocrinology 2003; 144: 2695-2703.
35. Zainia S, Pettersson L, Ahrén B, Brånén L, Hassan AB, Lindholm M, Mattsson R, Thy-berg J, Nilsson J: Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem 2002; 277:4505-4511.